MedPath
TGA Approval

ULTOMIRIS ravulizumab rch 10 mg/mL concentrated solution for intravenous infusion vial (311926)

311926

ULTOMIRIS ravulizumab rch 10 mg/mL concentrated solution for intravenous infusion vial

Alexion Pharmaceuticals Australasia Pty Ltd

October 17, 2019

Medicine

Medicine

Active

Registered

Active Ingredients

ravulizumab

© Copyright 2025. All Rights Reserved by MedPath
ULTOMIRIS ravulizumab rch 10 mg/mL concentrated solution for intravenous infusion vial (311926) - TGA 批准文号 | MedPath